Successful treatment of IgG4-related hypertrophic pachymeningitis with induction rituximab and dexamethasone followed by maintenance rituximab

Karan Seegobin; Muhamad Alhaj Moustafa; Nicole Gannon; Katelyn Keller; Jacquelyn Hastings; Vivek Gupta; Han W. Tun; Liuyan Jiang

doi:10.22541/au.159946954.49575788

loading page

Successful treatment of IgG4-related hypertrophic pachymeningitis with induction rituximab and dexamethasone followed by maintenance rituximab

Karan Seegobin,
Muhamad Alhaj Moustafa,
Nicole Gannon,
Katelyn Keller,
Jacquelyn Hastings,
Vivek Gupta,
Han W. Tun,
Liuyan Jiang

Abstract

IgG4-related disease (IgG4RD) with intracranial involvement is rare. We report a 56-year-old male who had an excellent response to rituximab and dexamethasone after going undiagnosed for 5 years. After 3 years of rituximab maintenance, he has no evidence of disease on brain MRI.

04 Sep 2020Submitted to Clinical Case Reports

Show details

Hide details

07 Sep 2020Submission Checks Completed

07 Sep 2020Assigned to Editor

20 Sep 2020Reviewer(s) Assigned

09 Dec 2020Review(s) Completed, Editorial Evaluation Pending

09 Dec 2020Editorial Decision: Revise Minor

01 Jan 20211st Revision Received

04 Jan 2021Submission Checks Completed

04 Jan 2021Assigned to Editor

04 Jan 2021Review(s) Completed, Editorial Evaluation Pending

05 Jan 2021Reviewer(s) Assigned

09 Jan 2021Editorial Decision: Accept

Abstract

Peer review status:ACCEPTED